• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拯救脓毒症运动:我们曾身处何方,又将去往何处?

The Surviving Sepsis Campaign: Where have we been and where are we going?

作者信息

Dellinger R Phillip

机构信息

Professor and Chair of Medicine, Cooper Medical School of Rowan University, Camden, NJ, USA.

Adult Health Institute, and Senior Critical Care Attending, Cooper University Hospital, Camden, NJ, USA.

出版信息

Cleve Clin J Med. 2015 Apr;82(4):237-44. doi: 10.3949/ccjm.82gr.15001.

DOI:10.3949/ccjm.82gr.15001
PMID:25955458
Abstract

The Surviving Sepsis Campaign develops and promotes evidence-based guidelines and performance-improvement practices aimed at reducing deaths from sepsis worldwide. The most recent guidelines, published in 2013, provide detailed management strategies for acute care, fluid resuscitation, and vasopressor use. In addition, the campaign has developed simple, short protocols for what to do within 3 and 6 hours of recognition of sepsis. These protocols are associated with reduced mortality rates.

摘要

拯救脓毒症运动制定并推广基于证据的指南和绩效改进措施,旨在降低全球脓毒症导致的死亡人数。2013年发布的最新指南提供了急性护理、液体复苏和血管活性药物使用的详细管理策略。此外,该运动还制定了在识别脓毒症后3小时和6小时内该采取何种措施的简单简短方案。这些方案与死亡率降低相关。

相似文献

1
The Surviving Sepsis Campaign: Where have we been and where are we going?拯救脓毒症运动:我们曾身处何方,又将去往何处?
Cleve Clin J Med. 2015 Apr;82(4):237-44. doi: 10.3949/ccjm.82gr.15001.
2
The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients.拯救脓毒症运动:成年患者液体复苏和血管活性药物治疗研究重点
Crit Care Med. 2021 Apr 1;49(4):623-635. doi: 10.1097/CCM.0000000000004864.
3
The role of bundles in sepsis care.束状结构在脓毒症治疗中的作用。
Crit Care Clin. 2006 Jul;22(3):521-9, x. doi: 10.1016/j.ccc.2006.03.005.
4
Current controversies in the support of sepsis.脓毒症支持治疗中的当前争议
Curr Opin Crit Care. 2014 Dec;20(6):681-4. doi: 10.1097/MCC.0000000000000154.
5
A users' guide to the 2016 Surviving Sepsis Guidelines.《2016年拯救脓毒症指南用户指南》
Intensive Care Med. 2017 Mar;43(3):299-303. doi: 10.1007/s00134-017-4681-8. Epub 2017 Jan 18.
6
Initial resuscitation guided by the Surviving Sepsis Campaign recommendations and early echocardiographic assessment of hemodynamics in intensive care unit septic patients: a pilot study.以《拯救脓毒症运动》指南指导的初始复苏和重症监护室脓毒症患者血流动力学的早期超声心动图评估:一项初步研究。
Crit Care Med. 2012 Oct;40(10):2821-7. doi: 10.1097/CCM.0b013e31825bc565.
7
The Surviving Sepsis Campaign: past, present and future.拯救脓毒症运动:过去、现在与未来。
Trends Mol Med. 2014 Apr;20(4):192-4. doi: 10.1016/j.molmed.2014.02.001.
8
Evolution of Sepsis Management: From Early Goal-Directed Therapy to Personalized Care.脓毒症管理的演变:从早期目标导向治疗到个性化护理。
Adv Surg. 2016 Sep;50(1):221-34. doi: 10.1016/j.yasu.2016.04.002. Epub 2016 Jun 29.
9
Reducing mortality in severe sepsis and septic shock.降低严重脓毒症和脓毒性休克的死亡率。
Semin Respir Crit Care Med. 2011 Apr;32(2):195-205. doi: 10.1055/s-0031-1275532. Epub 2011 Apr 19.
10
Update on the management of infection in patients with severe sepsis.严重脓毒症患者感染管理的最新进展
Dimens Crit Care Nurs. 2008 Nov-Dec;27(6):244-8. doi: 10.1097/01.DCC.0000338868.31917.0e.

引用本文的文献

1
Efficacy and Safety of a Balanced Gelatine Solution for Fluid Resuscitation in Sepsis: A Prospective, Randomised, Controlled, Double-Blind Trial-GENIUS Trial.一种平衡明胶溶液用于脓毒症液体复苏的有效性和安全性:一项前瞻性、随机、对照、双盲试验——GENIUS试验
J Clin Med. 2025 Jul 28;14(15):5323. doi: 10.3390/jcm14155323.
2
The global, regional, and national burdens of maternal sepsis and other maternal infections and trends from 1990 to 2021 and future trend predictions: results from the Global Burden of Disease study 2021.1990年至2021年全球、区域和国家层面孕产妇败血症及其他孕产妇感染的负担、趋势以及未来趋势预测:《2021年全球疾病负担研究》结果
BMC Pregnancy Childbirth. 2025 Mar 14;25(1):285. doi: 10.1186/s12884-025-07409-2.
3
Mortality among adult patients with sepsis and septic shock in Korea: a systematic review and meta-analysis.
韩国成年脓毒症和脓毒性休克患者的死亡率:一项系统评价和荟萃分析。
Clin Exp Emerg Med. 2023 Jun;10(2):157-171. doi: 10.15441/ceem.23.005. Epub 2023 Mar 7.
4
Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational study.新型冠状病毒肺炎严重程度评估工具的实用性:一项多中心观察性研究。
Clin Med (Lond). 2022 Jan;22(1):63-70. doi: 10.7861/clinmed.2020-1107.
5
Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsis.早期目标控制胶体容量复苏与平衡电解质溶液复苏对严重脓毒症/脓毒性休克患者的疗效和安全性:一项前瞻性、随机、对照、双盲、多中心、国际临床试验的研究方案、设计和原理:GENIUS-Gel 用于 ICU 和脓毒症。
Trials. 2021 Jun 2;22(1):376. doi: 10.1186/s13063-021-05311-8.
6
Association of Health Insurance Status with Outcomes of Sepsis in Adult Patients: A Retrospective Cohort Study.成人患者医疗保险状态与脓毒症结局的关联:一项回顾性队列研究
Int J Environ Res Public Health. 2021 May 27;18(11):5777. doi: 10.3390/ijerph18115777.
7
Epidemiological Trend of Sepsis in Patients with Hospital Admissions Related to Hepatitis C in Spain (2000-2015): A Nationwide Study.西班牙丙型肝炎相关住院患者败血症的流行病学趋势(2000 - 2015年):一项全国性研究
J Clin Med. 2020 May 26;9(6):1607. doi: 10.3390/jcm9061607.
8
Calculated initial parenteral treatment of bacterial infections: Sepsis.细菌性感染的初始肠外治疗方案计算:脓毒症
GMS Infect Dis. 2020 Mar 26;8:Doc09. doi: 10.3205/id000053. eCollection 2020.
9
Appropriate empirical antibiotic therapy and mortality: Conflicting data explained by residual confounding.适当的经验性抗生素治疗与死亡率:残余混杂解释了矛盾的数据。
PLoS One. 2019 Nov 19;14(11):e0225478. doi: 10.1371/journal.pone.0225478. eCollection 2019.
10
Sepsis: The evolution in definition, pathophysiology, and management.脓毒症:定义、病理生理学及管理的演变
SAGE Open Med. 2019 Mar 21;7:2050312119835043. doi: 10.1177/2050312119835043. eCollection 2019.